I agree Viking. I did find it odd that they would bother to address the rumor that the P3 trial results will not be presented at ASCO. There are rumors all over the place so why bother to set that one straight? That said, when she said they won't be presenting the results AT ASCO she may have meant that they won't be doing so because the TLD PR and journal article will be out before then.
Once TLD is out, they need a new CEO. Someone capable of moving things along. Almost a year ago it would take about 6 weeks for TLD to get to us. In Dec they decided to go into a publication. Annoying.
I transferred money today to buy more. The investment thesis doesn’t change even if she is somewhat incompetent. We know the UK and Germany already agreed to the SAP. I imagine the FDA did as well because of DL. We know it is used in the UK and at UCLA. They would stop using it if it was grapefruit juice.
It will be accepted as treatment immediately in the UK. I think hashing and rehashing the data is to give the best light for pricing power. But still very annoyed with this CEO. I do not care if is her baby. Enough reading of notes. Take some live questions.
Exactly!!! The Wednesday PR covered all the questions from the shareholders with today's meeting serving as a verbal confirmation thereof. They presented all the good news on Wednesday and today's GREAT NEWS is that there's no bad news!!! Bad news would have to be disclosed today!!! Northwest is beginning to act like the major company potential that they are!!!
you are absolutely right .. no surprises ... now we might be free of the everlasting "any day" "TLD at ASCO", "they work behind the curtain with BP" or worst "BO soon" they work and have their hands full analyzing data ... when they are done with it they have to write an article, it has to be read through and approved by the publishers, and maybe even go through peer review .. it will take months .after months.... my guess is that the release of TLD will come in Q3 at the earliest ..